Literature DB >> 25421673

Epigenetics of colorectal cancer.

Wenji Yan1, Mingzhou Guo.   

Abstract

Colorectal cancer (CRC) is one of most common malignancies and a leading cause of cancer related deaths worldwide. Epigenetic change is an important mechanism of colorectal carcinogenesis. Accumulation of epigenetic changes was found in colorectal cancer and other tumors. Aberrant changes in DNA methylation, histone modification, imprinting, and noncoding RNAs were frequently found in human colorectal cancer. Epigenetic changes may serve as a diagnostic, prognostic, and chemo-sensitive marker. It also becomes a cancer preventive or therapeutic target in some circumstances.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25421673     DOI： 10.1007/978-1-4939-1804-1_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  11 in total

Review 1.  Epigenetic Biomarkers in Colorectal Cancer.

Authors:  Mukesh Verma; Vineet Kumar
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

2.  KRAS Promoter Methylation Status and miR-18a-3p and miR-143 Expression in Patients With Wild-type KRAS Gene in Colorectal Cancer.

Authors:  Jehison Alirio Herrera-Pulido; Orlando Ricaurte Guerrero; Jinneth Acosta Forero; Pablo Moreno-Acosta; Alfredo Romero-Rojas; Carolina Sanabria; Gustavo Hernández; Martha Lucía Serrano
Journal:  Cancer Diagn Progn       Date:  2022-09-03

3.  Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior.

Authors:  Elizabeth Hibler
Journal:  Curr Colorectal Cancer Rep       Date:  2015-09-19

4.  A Comprehensive Meta-Analysis of MicroRNAs for Predicting Colorectal Cancer.

Authors:  Lin Yan; Wenhua Zhao; Haihua Yu; Yansen Wang; Yuanshui Liu; Chao Xie
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.

Authors:  Nadia Ferlazzo; Monica Currò; Angelo Zinellu; Daniela Caccamo; Gaetano Isola; Valeria Ventura; Ciriaco Carru; Giovanni Matarese; Riccardo Ientile
Journal:  Int J Mol Sci       Date:  2017-03-29       Impact factor: 5.923

Review 6.  The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer.

Authors:  Curt Balch; Jayaram B Ramapuram; Amit K Tiwari
Journal:  Front Pharmacol       Date:  2017-05-19       Impact factor: 5.810

7.  Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.

Authors:  Wenji Yan; Kongming Wu; James G Herman; Xiuduan Xu; Yunsheng Yang; Guanghai Dai; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2018-05-23       Impact factor: 6.551

Review 8.  The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.

Authors:  Kai Ma; Baoping Cao; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2016-04-22       Impact factor: 6.551

9.  IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.

Authors:  Maria Buoncervello; Giulia Romagnoli; Mariachiara Buccarelli; Alessandra Fragale; Elena Toschi; Stefania Parlato; Donatella Lucchetti; Daniele Macchia; Massimo Spada; Irene Canini; Massimo Sanchez; Mario Falchi; Martina Musella; Mauro Biffoni; Filippo Belardelli; Imerio Capone; Alessandro Sgambato; Lucia Ricci Vitiani; Lucia Gabriele
Journal:  Oncotarget       Date:  2016-05-03

10.  Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.

Authors:  Yuzhu Wang; Tao He; James G Herman; Enqiang Linghu; Yunsheng Yang; François Fuks; Fuyou Zhou; Linjie Song; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2017-10-18       Impact factor: 6.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.